60 Participants Needed

Telerehabilitation Physical Activity for Mild Cognitive Impairment

RH
Overseen ByRashelle Hoffman, PT, DPT, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Creighton University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores ways to help individuals with mild memory problems, known as amnestic mild cognitive impairment, become more active. The study tests a 12-week program delivered through mobile technology to increase daily steps, aiming to slow the progression toward Alzheimer's Disease. Participants pair with a caregiver and divide into two groups: one receives the new activity program, called the Telerehabilitation Physical Activity Behavioral (TPAB) intervention, and the other follows their usual routine. This study suits those diagnosed with amnestic mild cognitive impairment who are currently not very active and have a caregiver willing to join the trial. As an unphased trial, it offers a unique opportunity to contribute to innovative research that could enhance quality of life.

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications, but it requires that you have been on stable doses of medication for at least the previous 30 days before starting the study.

What prior data suggests that this telerehabilitation physical activity intervention is safe for individuals with mild cognitive impairment?

Research has shown that telerehabilitation physical activity programs are generally safe for people with mild memory and thinking problems. Early results suggest these programs are easy to manage and have few side effects.

Studies have found that exercise programs using technology can benefit older adults, even those with mild cognitive issues. Participants usually report positive experiences and do not encounter serious problems.

Although few studies have examined the exact program in this trial, similar programs have not raised major safety concerns. This type of program primarily focuses on increasing daily steps, a safe and common exercise goal. Overall, evidence suggests that the telerehabilitation approach is safe, but participants should consult their healthcare providers.12345

Why are researchers excited about this trial?

Researchers are excited about the Telerehabilitation Physical Activity Behavioral (TPAB) intervention for mild cognitive impairment because it takes a novel approach by integrating technology with behavior-change techniques. Unlike traditional treatments that may focus on medication or in-person therapy, TPAB leverages telerehabilitation to deliver weekly sessions remotely, making it accessible and convenient for patients and their caregivers. This method emphasizes patient-centered communication and uses established theories like Social Cognitive Theory and Operant Conditioning to encourage increased daily physical activity, such as taking more steps. The hope is that this innovative approach will not only improve physical activity levels but also potentially enhance cognitive function and quality of life for individuals with mild cognitive impairment.

What evidence suggests that the Telerehabilitation physical activity behavioral intervention is effective for improving physical activity in individuals with mild cognitive impairment?

Research has shown that telerehabilitation programs, which use mobile technology to encourage exercise, can increase physical activity in older adults, including those without memory problems. One study found that these programs significantly boost daily step counts. This trial will evaluate the Telerehabilitation Physical Activity Behavioral (TPAB) intervention, which participants may receive, to determine its effectiveness in slowing the progression from mild memory issues to Alzheimer's Disease. Studies have also shown that regular exercise can improve overall health and quality of life, even for those with memory challenges. Although specific data on telerehabilitation's impact on memory is limited, this method appears promising for increasing physical activity and potentially reducing dementia risk.12456

Are You a Good Fit for This Trial?

This trial is for pairs of individuals where one person has mild cognitive impairment (MCI) aged between 50-85, and their caregiver who is over 19. The patient should have a diagnosis of amnestic MCI, score within a specific range on a cognitive assessment test, not be very physically active, and be stable on medications. Both must speak English and have internet access.

Inclusion Criteria

Have a computer/wireless device with Internet access
I have been diagnosed with memory loss that affects my daily life.
A score of 18-24 on the Montreal Cognitive Assessment indicating possible MCI (patient only)
See 10 more

Exclusion Criteria

I have health issues that could make walking unsafe for me during the study.
I have a diagnosed neurological condition.
My blood pressure has been stable for the last six months.
See 1 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive a 12-week mobile-health technology physical activity behavior change intervention

12 weeks
12 weekly sessions (remote)

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Telerehabilitation physical activity behavioral (TPAB) intervention
Trial Overview The study tests a Telerehabilitation physical activity behavioral intervention using mobile-health technology to improve daily physical activity in patients with MCI. Thirty pairs will either receive this 12-week intervention or usual care to see if it's feasible and effective at increasing steps measured by accelerometry.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: Telerehabilitation physical activity behavioral (TPAB) interventionExperimental Treatment1 Intervention
Group II: Control GroupActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Creighton University

Lead Sponsor

Trials
128
Recruited
25,800+

National Institutes of Health (NIH)

Collaborator

Trials
2,896
Recruited
8,053,000+

Published Research Related to This Trial

This study tests a new tele-rehabilitation program designed for individuals with Mild Cognitive Impairment (MCI) and Vascular Cognitive Impairment (VCI), combining cognitive, physical, and social activities over 8 weeks to help prevent cognitive decline.
Involving 60 participants in a randomized controlled trial, the program aims to assess its effectiveness in improving cognitive functioning, physical health, and quality of life compared to a control group, with evaluations at baseline, after the program, and at a 12-month follow-up.
The Games for Older Adults Active Life (GOAL) Project for People With Mild Cognitive Impairment and Vascular Cognitive Impairment: A Study Protocol for a Randomized Controlled Trial.Fabbri, L., Mosca, IE., Gerli, F., et al.[2020]
Home-based telerehabilitation exercise programs using videoconferencing and activity tracking devices were found to be feasible for individuals with moderate to severe traumatic brain injury (TBI), with high adherence and satisfaction reported by participants and their family partners.
The study suggests that telerehabilitation can enhance access to physiotherapy for TBI patients, allowing them to focus on therapy rather than travel, although further research is needed to evaluate its effectiveness on physical outcomes like balance and mobility.
Remotely Supervised Exercise Programmes to Improve Balance, Mobility, and Activity Among People with Moderate to Severe Traumatic Brain Injury: Description and Feasibility.O'Neil, J., Egan, M., Marshall, S., et al.[2023]
A telerehabilitation program for patients with multi-domain amnestic Mild Cognitive Impairment (md-aMCI) showed significant improvements in cognitive performance, particularly in delayed and working memory, language skills, and overall cognition, after 15 weeks of intervention with 30 participants.
The study suggests that telerehabilitation can be an effective alternative to traditional face-to-face therapies, especially during challenging times like the pandemic, providing hope for stabilizing cognitive decline in md-aMCI patients.
Evaluation of the Efficacy and Feasibility of a Telerehabilitation Program Using Language and Cognitive Exercises in Multi-Domain Amnestic Mild Cognitive Impairment.Nousia, A., Pappa, E., Siokas, V., et al.[2023]

Citations

Improving Physical Activity With Cognitive ImpairmentThe primary objective of this pilot study is to determine the feasibility and preliminary efficacy of a telerehabilitation physical activity behavioral (TPAB) ...
A Scoping Review for Usage of Telerehabilitation among ...Most outcomes of these studies included quality of life or functional health patterns, cognitive function, behavioral status, adherence towards ...
Improving Physical Activity With Cognitive ImpairmentThe intervention group will receive a 12-week mobile-health technology physical activity behavior change intervention structured to improve ...
Omahac, Nebraska Clinical Research TrialsThe primary objective of this pilot study is to determine the feasibility and preliminary efficacy of a telerehabilitation physical activity behavioral (TPAB) ...
Effects of home-based and telerehabilitation exercise on ...There is a low evidence on the effects of home-based physical activity or exercise on global cognitive function, neuropsychiatric symptoms and ADL.
Technology-based group exercise interventions for people ...This scoping review will explore evidence relating to the use of technology-based group exercise by people with dementia or mild cognitive impairment.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of ServiceยทPrivacy PolicyยทCookiesยทSecurity